Table 1: Baseline demographic and clinical characteristics of study participants .

Characteristic: (%)Glucomannan Control

 Gender
  Male3 (13%)4 (16.7%)
  Female20 (87%)20 (83.3%)
 Race/ethnic group
  White9 (39.1%)13 (54.2%)
  Black8 (34.8%)6 (25.0%)
  Hispanic4 (17.4%)5 (20.8%)
  Other2 (8.6%)0 (0%)
Characteristic: mean (±SD)
 Age, years35.59 (12.21)41.59 (10.08)
 Height, ft/in5.42 (.41)5.50 (.30)
 Weight, kg83.27 (12.32)85.36 (12.41)
 Body mass index, kg/m230.70 (2.86)30.91 (3.28)
 Waist circumference, cm94.92 (10.25)96.73 (11.03)
 Hip circumference, cm112.99 (8.05)113.45 (7.41)
 Fat mass, kg32.93 (2.43)31.91 (2.37)
 Fat-free mass, kg51.99 (3.51)50.71 (3.61)
 Total cholesterol, mg/dL209.20 (41.82) 204.29 (31.04)
 LDL cholesterol, mg/dL135.95 (33.41) 129.76 (27.03)
 HDL cholesterol, mg/dL40.45 (8.49) 53.24 (12.50)
 Triglycerides, mg/dL123.40 (61.26) 106.90 (27.67)
 Fasting glucose, mg/dL87.05 (10.35) 86.00 (11.29)